Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Praxis Precision Medicines Inc (PRAX)

Praxis Precision Medicines Inc (PRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,361,692
  • Shares Outstanding, K 18,638
  • Annual Sales, $ 2,450 K
  • Annual Income, $ -123,280 K
  • EBIT $ -164 M
  • EBITDA $ -164 M
  • 60-Month Beta 2.67
  • Price/Sales 561.20
  • Price/Cash Flow N/A
  • Price/Book 3.42

Options Overview Details

View History
  • Implied Volatility 73.76% ( +5.20%)
  • Historical Volatility 51.90%
  • IV Percentile 5%
  • IV Rank 1.49%
  • IV High 416.76% on 11/27/23
  • IV Low 68.56% on 11/20/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 243
  • Volume Avg (30-Day) 951
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 23,127
  • Open Int (30-Day) 26,624

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -2.84
  • Number of Estimates 7
  • High Estimate -2.45
  • Low Estimate -3.05
  • Prior Year -2.97
  • Growth Rate Est. (year over year) +4.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.83 +26.63%
on 11/06/24
86.93 -14.30%
on 11/12/24
+2.25 (+3.11%)
since 10/22/24
3-Month
48.22 +54.50%
on 08/23/24
86.93 -14.30%
on 11/12/24
+24.74 (+49.72%)
since 08/22/24
52-Week
14.77 +404.23%
on 12/15/23
86.93 -14.30%
on 11/12/24
+57.55 (+339.53%)
since 11/22/23

Most Recent Stories

More News
Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences

PRAX : 74.50 (+1.97%)
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results

PRAX : 74.50 (+1.97%)
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024

PRAX : 74.50 (+1.97%)
Stocks Give Up Early Gains as Nvidia Weighs on Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.36%. Stock indexes...

$SPX : 5,969.34 (+0.35%)
SPY : 595.51 (+0.31%)
$DOWI : 44,296.51 (+0.97%)
DIA : 443.16 (+0.95%)
$IUXX : 20,776.23 (+0.17%)
QQQ : 505.79 (+0.16%)
ZNZ24 : 109-205s (+0.13%)
UPS : 134.82 (+2.63%)
IP : 59.32 (+0.24%)
MMM : 128.42 (+0.86%)
NVDA : 141.95 (-3.22%)
GFS : 42.80 (+1.90%)
Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND Filing

/PRNewswire/ -- Invitae (NYSE: NVTA) and Praxis Precision Medicines, Inc. (NASDAQ: PRAX), today announced that real-world clinical insights from Invitae's...

NVTA : 0.0195 (+2.63%)
IONS : 34.01 (+0.21%)
PRAX : 74.50 (+1.97%)
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2022 Financial Results

PRAX-944 Phase 2b Essential1 Study topline results expected in 4Q22; primary endpoint updated to efficacy PRAX-562 Phase 1 study completed, confirming...

PRAX : 74.50 (+1.97%)
Praxis Precision Medicines to Present at 2022 Wedbush PacGrow Healthcare Conference

BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...

PRAX : 74.50 (+1.97%)
Praxis Precision Medicines Reports Negative Results from PRAX-114 Phase 2/3 Monotherapy Aria Study in Patients with Major Depressive Disorder

Aria Study did not achieve statistical significance on the primary endpoint Strategic realignment to focus resources on Movement Disorders and Epilepsy...

PRAX : 74.50 (+1.97%)
Praxis Precision Medicines Adds Global Business Expertise to Board of Directors with Appointment of Jill DeSimone

BOSTON, May 23, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...

PRAX : 74.50 (+1.97%)
Praxis Precision Medicines to Present at Upcoming Investor Conferences

BOSTON, May 11, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...

PRAX : 74.50 (+1.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Praxis Precision Medicines Inc. is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis Precision Medicines Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 81.37
2nd Resistance Point 78.71
1st Resistance Point 76.60
Last Price 74.50
1st Support Level 71.83
2nd Support Level 69.17
3rd Support Level 67.06

See More

52-Week High 86.93
Last Price 74.50
Fibonacci 61.8% 59.37
Fibonacci 50% 50.85
Fibonacci 38.2% 42.34
52-Week Low 14.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar